Three-weekly doses of azithromycin for Indigenous infants hospitalised with bronchiolitis: A multicentre, randomised, placebo-controlled trial

• Váldodahkkit: Gabrielle Britt McCallum (Dahkki), Peter S Morris (Dahkki), Keith eGrimwood (Dahkki), Carolyn eMaclennan (Dahkki), Andrew V White (Dahkki), Mark D Chatfield (Dahkki), Theo P Sloots (Dahkki), Ian M Mackay (Dahkki), Heidi eSmith-Vaughan (Dahkki), Clare C Mckay (Dahkki), Lesley A Versteegh (Dahkki), Nerida eJacobsen (Dahkki), Charmaine eMobberley (Dahkki), Catherine Ann Byrnes (Dahkki), Anne B Chang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2015-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background Bronchiolitis is a major health burden in infants globally, particularly among Indigenous populations. It is unknown if 3-weeks of azithromycin improve clinical outcomes beyond the hospitalisation period. In an international, double-blind randomised controlled trial, we determined if 3-we...